scispace - formally typeset
Y

Yuru Shang

Researcher at Dalian Medical University

Publications -  7
Citations -  74

Yuru Shang is an academic researcher from Dalian Medical University. The author has contributed to research in topics: Lymph node & Cancer. The author has an hindex of 4, co-authored 6 publications receiving 48 citations.

Papers
More filters
Journal ArticleDOI

Andrographolide impairs alpha-naphthylisothiocyanate-induced cholestatic liver injury in vivo

TL;DR: The data suggest that andrographolide may impair cholestatic liver injury via anti-inflammatory and anti-oxidative stress.
Journal ArticleDOI

Pancreaticoduodenectomy is justified in a subset of elderly patients with pancreatic ductal adenocarcinoma: A population-based retrospective cohort study of 4,283 patients.

TL;DR: Advanced age (age ≥75 years) is not an independent risk factor for diseases specific survival (DSS) and PD is justified in a subset of elderly PDAC patients; however, it should be performed in a high-volume center to minimize the risk of post operative complications.
Journal ArticleDOI

The number of positive lymph node is a better predictor of survival than the lymph node metastasis status for pancreatic neuroendocrine neoplasms: A retrospective cohort study.

TL;DR: The NPLN seems more meaningful than the lymph node metastasis status as prognostic factor for survival in pancreatic adenocarcinoma cohorts, and taking into account the prognostic value of NPLn for pNENs might improve the current TNM staging systems.
Journal ArticleDOI

A modified M-stage classification based on the metastatic patterns of pancreatic neuroendocrine neoplasms: a population-based study

TL;DR: The modified M-stage classification is superior to both AJCC and ENETS M- stage classifications in the prognosis of pNENs and had superior discriminatory capability than both the American Joint Committee on Cancer (AJCC) and the European Neuroendocrine Tumor Society (ENETS) M-Stage classifications.